Cargando…
EPLIN: a fundamental actin regulator in cancer metastasis?
Treatment of malignant disease is of paramount importance in modern medicine. In 2012, it was estimated that 162,000 people died from cancer in the UK which illustrates a fundamental problem. Traditional treatments for cancer have various drawbacks, and this creates a considerable need for specific,...
Autores principales: | Collins, Ross J., Jiang, Wen G., Hargest, Rachel, Mason, Malcolm D., Sanders, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661189/ https://www.ncbi.nlm.nih.gov/pubmed/26350886 http://dx.doi.org/10.1007/s10555-015-9595-8 |
Ejemplares similares
-
EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance
por: Zeng, Jianyuan, et al.
Publicado: (2022) -
The non-coding transcriptome as a dynamic regulator of cancer metastasis
por: Crea, Francesco, et al.
Publicado: (2013) -
Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis
por: Sutherland, Rachel, et al.
Publicado: (2020) -
The challenge of targeting metastasis
por: Fidler, Isaiah J., et al.
Publicado: (2015) -
Cell–cell and cell–matrix dynamics in intraperitoneal cancer metastasis
por: Sodek, Katharine L., et al.
Publicado: (2012)